CymitQuimica logo

CAS 2102933-95-7

:

Formula:C14H22Cl2N2
InChI:InChI=1S/C14H20N2.2ClH/c1-2-4-11(5-3-1)13-10-14(13)16-12-6-8-15-9-7-12;;/h1-5,12-16H,6-10H2;2*1H/t13-,14+;;/m0../s1
InChI key:PJFZOGMSPBHPNS-WICJZZOFSA-N
SMILES:C1CNCCC1N[C@@H]2C[C@H]2C3=CC=CC=C3.Cl.Cl
Found 5 products.
  • GSK-LSD1 dihydrochloride

    CAS:
    GSK-LSD1 dihydrochloride
    Formula:C14H22Cl2N2
    Purity:98.5%
    Molecular weight:289.24

    Ref: 54-BUP12461

    5mg
    98.00€
    10mg
    154.00€
    25mg
    295.00€
    50mg
    440.00€
    100mg
    708.00€
    500mg
    1,367.00€
  • GSK-LSD1 (hydrochloride)

    CAS:
    Formula:C14H22Cl2N2
    Purity:98%
    Molecular weight:289.2439

    Ref: IN-DA01EO5W

    10mg
    194.00€
    25mg
    298.00€
    50mg
    538.00€
    100mg
    563.00€
    250mg
    818.00€
  • GSK-LSD1 dihydrochloride

    CAS:
    GSK-LSD1 dihydrochloride: potent LSD1 inhibitor, >1000x selective over MAO-A/B, LSD2, IC50: 16 nM.
    Formula:C14H22Cl2N2
    Purity:98.72% - >99.99%
    Color and Shape:Yellow Solid
    Molecular weight:289.24
  • GSK LSD1 Dihydrochloride

    Controlled Product
    CAS:

    Applications GSK LSD1 Dihydrochloride is an irreversible mechanism-based inhibitor of LSD1. Lysine-specific demthylase 1 (LSD1) belonges to the flavin adenine dinucleotide (FAD) family-dependant amine oxidases that include MAOs and PAOs. Inhibits cell proliferation in cancer cell lines.
    References Shi, Y. et al.: Cell 119, 941 (2004); Forneris, F. J. Biol. Chem. 280, 41360 (2005);

    Formula:C14H22Cl2N2
    Color and Shape:Neat
    Molecular weight:342.407

    Ref: TR-G797570

    100mg
    1,933.00€
  • GSK-LSD1 dihydrochloride

    CAS:
    GSK-LSD1 is a potential drug for the treatment of cervical cancer and myeloid leukemia. GSK-LSD1 has been shown to induce autophagy, which is a process by which cells break down and recycle their own cellular components. This process also plays a key role in the development of bowel disease, as well as inflammatory bowel disease and leukemias. GSK-LSD1 was shown to inhibit the growth of human myeloid leukemia cells (THP-1) in vitro and reduced the number of leukemic mice with leukemia. The mechanism by which GSK-LSD1 inhibits tumor cell proliferation is unclear, but may be related to its ability to inhibit cell factor or stem cell factor expression.
    Formula:C14H22Cl2N2
    Purity:Min. 95%
    Molecular weight:289.24 g/mol

    Ref: 3D-CJD93395

    5mg
    310.00€
    10mg
    412.00€
    25mg
    687.00€
    50mg
    1,042.00€
    100mg
    1,572.00€